Identification of Expression Patterns and Potential Prognostic Significance of m5C-Related Regulators in Head and Neck Squamous Cell Carcinoma

被引:12
作者
Han, Zhenyuan [1 ,2 ]
Yang, Biao [3 ]
Wang, Yu [1 ,2 ]
Zeng, Xiuxia [4 ]
Tian, Zhen [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Oral Pathol, Sch Med, Shanghai, Peoples R China
[2] Natl Clin Res Ctr Oral Dis, Shanghai, Peoples R China
[3] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai, Peoples R China
[4] Putian Hanjiang Hosp, Dept Stomatol, Putian, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
上海市自然科学基金;
关键词
head and neck squamous cell carcinoma; m(5)C RNA methylation; prognostic signature; TCGA; expression pattern;
D O I
10.3389/fonc.2021.592107
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5-Methylcytosine (m(5)C) methylation is a major epigenetic technique of RNA modification and is dynamically mediated by m(5)C "writers," "erasers," and "readers." m(5)C RNA modification and its regulators are implicated in the onset and development of many tumors, but their roles in head and neck squamous cell carcinoma (HNSCC) have not yet been completely elucidated. In this study, we examined expression patterns of core m(5)C regulators in the publicly available HNSCC cohort via bioinformatic methods. The differentially expressed m(5)C regulators could divide the HNSCC cohort into four subgroups with distinct prognostic characteristics. Furthermore, a three-gene expression signature model, comprised of NSUN5, DNMT1, and DNMT3A, was established to identify individuals with a high or low risk of HNSCC. To explore the underlying mechanism in the prognosis of HNSCC, screening of differentially expressed genes, followed by the analysis of functional and pathway enrichment, from individuals with high- or low-risk HNSCC was performed. The results revealed a critical role for m(5)C RNA modification in two aspects of HNSCC: (1) dynamic m(5)C modification contributes to the regulation of HNSCC progression and (2) expression patterns of NSUN5, DNMT1, and DNMT3A help to predict the prognosis of HNSCC.
引用
收藏
页数:16
相关论文
共 62 条
  • [1] Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck Cancer
    Ahn, Peter H.
    Machtay, Mitchell
    Anne, Pramila R.
    Cognetti, David
    Keane, William M.
    Wuthrick, Evan
    Dicker, Adam P.
    Axelrod, Rita S.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (05): : 441 - 446
  • [2] YebU is a m5C methyltransferase specific for 16 S rRNA nucleotide 1407
    Andersen, Niels Moller
    Douthwaite, Stephen
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2006, 359 (03) : 777 - 786
  • [3] Argiris Athanassios, 2019, J Clin Oncol, V37, P3266, DOI 10.1200/JCO.19.00555
  • [4] Gene Ontology: tool for the unification of biology
    Ashburner, M
    Ball, CA
    Blake, JA
    Botstein, D
    Butler, H
    Cherry, JM
    Davis, AP
    Dolinski, K
    Dwight, SS
    Eppig, JT
    Harris, MA
    Hill, DP
    Issel-Tarver, L
    Kasarskis, A
    Lewis, S
    Matese, JC
    Richardson, JE
    Ringwald, M
    Rubin, GM
    Sherlock, G
    [J]. NATURE GENETICS, 2000, 25 (01) : 25 - 29
  • [5] LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma
    Ban, Yuanyuan
    Tan, Pingqing
    Cai, Jing
    Li, Junjun
    Hu, Meng
    Zhou, Ying
    Mei, Yan
    Tan, Yixin
    Li, Xiaoling
    Zeng, Zhaoyang
    Xiong, Wei
    Li, Guiyuan
    Li, Xiayu
    Yi, Mei
    Xiang, Bo
    [J]. MOLECULAR ONCOLOGY, 2020, 14 (06) : 1282 - 1296
  • [6] Role of RNA modifications in cancer
    Barbieri, Isaia
    Kouzarides, Tony
    [J]. NATURE REVIEWS CANCER, 2020, 20 (06) : 303 - 322
  • [7] MODOMICS: a database of RNA modification pathways. 2017 update
    Boccaletto, Pietro
    Machnicka, Magdalena A.
    Purta, Elzbieta
    Piatkowski, Pawe
    Baginski, Blazej
    Wirecki, Tomasz K.
    de Crecy-Lagard, Valerie
    Ross, Robert
    Limbach, Patrick A.
    Kotter, Annika
    Helm, Mark
    Bujnicki, Janusz M.
    [J]. NUCLEIC ACIDS RESEARCH, 2018, 46 (D1) : D303 - D307
  • [8] Eukaryotic 5-methylcytosine (m5C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease
    Bohnsack, Katherine E.
    Hoebartner, Claudia
    Bohnsack, Markus T.
    [J]. GENES, 2019, 10 (02):
  • [9] The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
    Cerami, Ethan
    Gao, Jianjiong
    Dogrusoz, Ugur
    Gross, Benjamin E.
    Sumer, Selcuk Onur
    Aksoy, Buelent Arman
    Jacobsen, Anders
    Byrne, Caitlin J.
    Heuer, Michael L.
    Larsson, Erik
    Antipin, Yevgeniy
    Reva, Boris
    Goldberg, Arthur P.
    Sander, Chris
    Schultz, Nikolaus
    [J]. CANCER DISCOVERY, 2012, 2 (05) : 401 - 404
  • [10] 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs
    Chen, Xin
    Li, Ang
    Sun, Bao-Fa
    Yang, Ying
    Han, Ya-Nan
    Yuan, Xun
    Chen, Ri-Xin
    Wei, Wen-Su
    Liu, Yanchao
    Gao, Chun-Chun
    Chen, Yu-Sheng
    Zhang, Mengmeng
    Ma, Xiao-Dan
    Liu, Zhuo-Wei
    Luo, Jun-Hang
    Lyu, Cong
    Wang, Hai-Lin
    Ma, Jinbiao
    Zhao, Yong-Liang
    Zhou, Fang-Jian
    Huang, Ying
    Xie, Dan
    Yang, Yun-Gui
    [J]. NATURE CELL BIOLOGY, 2019, 21 (08) : 978 - +